| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
|
J Virol
|
1980
|
5.59
|
|
2
|
The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation.
|
Cell
|
1986
|
5.13
|
|
3
|
Epstein-Barr virus (B95-8) DNA VII: molecular cloning and detailed mapping.
|
Proc Natl Acad Sci U S A
|
1980
|
5.02
|
|
4
|
Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma.
|
N Engl J Med
|
1995
|
4.62
|
|
5
|
Epstein-Barr virus replication in oropharyngeal epithelial cells.
|
N Engl J Med
|
1984
|
4.47
|
|
6
|
DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative.
|
Cell
|
1980
|
4.14
|
|
7
|
Replication of Epstein-Barr virus in human epithelial cells infected in vitro.
|
Nature
|
1984
|
2.81
|
|
8
|
DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments that contain DNA sequences which differ among strains of Epstein-Barr virus.
|
J Virol
|
1978
|
2.76
|
|
9
|
Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
|
Science
|
1999
|
2.61
|
|
10
|
Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.
|
Proc Natl Acad Sci U S A
|
1998
|
2.49
|
|
11
|
Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
|
J Virol
|
1990
|
2.43
|
|
12
|
Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt.
|
J Virol
|
2000
|
2.21
|
|
13
|
The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA.
|
Int J Cancer
|
1987
|
2.16
|
|
14
|
Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
|
J Virol
|
1992
|
2.14
|
|
15
|
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
|
J Virol
|
1997
|
2.05
|
|
16
|
Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
|
J Virol
|
1996
|
2.03
|
|
17
|
The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.
|
J Virol
|
1995
|
2.02
|
|
18
|
Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases.
|
J Infect Dis
|
1989
|
1.99
|
|
19
|
Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo.
|
J Virol
|
1991
|
1.91
|
|
20
|
Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia.
|
Proc Natl Acad Sci U S A
|
1990
|
1.90
|
|
21
|
A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
|
J Immunol
|
1998
|
1.85
|
|
22
|
Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia.
|
J Infect Dis
|
1995
|
1.75
|
|
23
|
Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells.
|
J Virol
|
2003
|
1.74
|
|
24
|
Sequence variation in the Epstein-Barr virus latent membrane protein 1.
|
J Gen Virol
|
1994
|
1.67
|
|
25
|
Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.
|
Am J Pathol
|
1995
|
1.58
|
|
26
|
Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-kappa B/Rel family proteins.
|
J Virol
|
1995
|
1.57
|
|
27
|
Epstein-Barr virus transcription in nasopharyngeal carcinoma.
|
J Virol
|
1983
|
1.57
|
|
28
|
Structural analyses of the Epstein-Barr virus BamHI A transcripts.
|
J Virol
|
1995
|
1.49
|
|
29
|
Establishment and characterization of an Epstein-Barr virus spontaneously transformed lymphocytic cell line derived from a hairy cell leukemia patient.
|
Leukemia
|
1991
|
1.41
|
|
30
|
Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
|
J Virol
|
1999
|
1.33
|
|
31
|
Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas.
|
J Virol
|
1993
|
1.31
|
|
32
|
Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains.
|
Virology
|
1999
|
1.28
|
|
33
|
Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.
|
J Virol
|
1997
|
1.28
|
|
34
|
Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia.
|
Proc Natl Acad Sci U S A
|
1992
|
1.27
|
|
35
|
Hairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.
|
J Virol
|
2000
|
1.27
|
|
36
|
Epstein-Barr virus: structure of the viral DNA and analysis of viral RNA in infected cells.
|
Biochim Biophys Acta
|
1979
|
1.25
|
|
37
|
Interaction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expression.
|
Mol Cell Biol
|
1998
|
1.24
|
|
38
|
EBV strain variation: geographical distribution and relation to disease state.
|
Virology
|
1992
|
1.23
|
|
39
|
The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.
|
J Virol
|
1995
|
1.22
|
|
40
|
Concatameric replication of Epstein-Barr virus: structure of the termini in virus-producer and newly transformed cell lines.
|
J Virol
|
1990
|
1.21
|
|
41
|
The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
|
Oncogene
|
1998
|
1.18
|
|
42
|
LMP1 signaling and activation of NF-kappaB in LMP1 transgenic mice.
|
Oncogene
|
2006
|
1.17
|
|
43
|
Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China.
|
Int J Cancer
|
1998
|
1.14
|
|
44
|
Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia.
|
J Virol
|
1994
|
1.13
|
|
45
|
A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection.
|
J Infect Dis
|
1991
|
1.10
|
|
46
|
The A20 protein interacts with the Epstein-Barr virus latent membrane protein 1 (LMP1) and alters the LMP1/TRAF1/TRADD complex.
|
Virology
|
1999
|
1.10
|
|
47
|
Alterations of the p53 gene in nasopharyngeal carcinoma.
|
J Virol
|
1992
|
1.09
|
|
48
|
Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase.
|
J Virol
|
1999
|
1.07
|
|
49
|
Variations among isolates of Epstein-Barr virus.
|
Ann N Y Acad Sci
|
1980
|
1.07
|
|
50
|
Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene.
|
J Gen Virol
|
1995
|
1.06
|
|
51
|
Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.
|
Virology
|
1998
|
1.04
|
|
52
|
Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression.
|
J Virol
|
1998
|
1.03
|
|
53
|
The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression.
|
J Virol
|
1994
|
1.00
|
|
54
|
Defective viral DNA in Epstein-Barr virus-associated oral hairy leukoplakia.
|
J Virol
|
1990
|
1.00
|
|
55
|
An Epstein-Barr virus protein interacts with Notch.
|
J Virol
|
2001
|
0.99
|
|
56
|
Two strains of Epstein-Barr virus (B95-8 and a P3HR-1 subclone) that lack defective genomes induce early antigen and cause abortive infection of Raji cells.
|
J Virol
|
1987
|
0.99
|
|
57
|
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
|
Cancer Res
|
1998
|
0.98
|
|
58
|
Epstein-Barr virus integration in human lymphomas and lymphoid cell lines.
|
Cancer
|
1992
|
0.97
|
|
59
|
No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.
|
Oncogene
|
1995
|
0.94
|
|
60
|
Alterations of the p53 gene in Epstein-Barr virus-associated immunodeficiency-related lymphomas.
|
J Virol
|
1994
|
0.91
|
|
61
|
The EGFR as a target for viral oncoproteins.
|
Trends Microbiol
|
1999
|
0.91
|
|
62
|
Epstein-Barr virus with transforming and early antigen-inducing ability originating from nasopharyngeal carcinoma: mapping of the viral genome.
|
J Gen Virol
|
1989
|
0.87
|
|
63
|
Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation.
|
Oncogene
|
2010
|
0.87
|
|
64
|
Epstein-Barr virus and malignant lymphoepithelial lesions of the salivary gland.
|
Arctic Med Res
|
1991
|
0.87
|
|
65
|
Epstein-Barr viral latency and cell immortalization as targets for antisense oligomers.
|
Ann N Y Acad Sci
|
1992
|
0.86
|
|
66
|
Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia.
|
J Am Acad Dermatol
|
1989
|
0.86
|
|
67
|
Mechanisms of expression of HHV8, EBV and HPV in selected HIV-associated oral lesions.
|
Oral Dis
|
2002
|
0.85
|
|
68
|
Purification of biologically active Epstein-Barr virus by affinity chromatography and non-ionic density gradient centrifugation.
|
J Virol Methods
|
1985
|
0.84
|
|
69
|
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
|
Cancer Res
|
2001
|
0.83
|
|
70
|
Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.
|
Virology
|
2001
|
0.83
|
|
71
|
Malignant neoplasms of the nasal cavity and paranasal sinuses: a series of 256 patients in Mexico City and Monterrey. Is air pollution the missing link?
|
Otolaryngol Head Neck Surg
|
2000
|
0.81
|
|
72
|
Amplification of Epstein-Barr virus (EBV) DNA by superinfection with a strain of EBV derived from nasopharyngeal carcinoma.
|
J Virol
|
1988
|
0.81
|
|
73
|
Expression of the c-fgr related transcripts in Epstein-Barr virus-associated malignancies.
|
Int J Cancer
|
1988
|
0.81
|
|
74
|
Oral hairy leukoplakia.
|
J Am Acad Dermatol
|
1990
|
0.81
|
|
75
|
Primary infection by Epstein-Barr virus presenting as aplastic anemia.
|
N Engl J Med
|
1983
|
0.81
|
|
76
|
The human DNA tumor viruses: human papilloma virus and Epstein-Barr virus.
|
Cancer Treat Res
|
1989
|
0.80
|
|
77
|
Differential effects of acyclovir and 9-(1,3-dihydroxy-2-propoxymethyl)guanine on herpes simplex virus and Epstein-Barr virus in a dually infected human lymphoblastoid cell line.
|
J Virol
|
1987
|
0.79
|
|
78
|
Mapping of putative transforming sequences of EBV DNA.
|
IARC Sci Publ
|
1978
|
0.79
|
|
79
|
Epstein-Barr virus and human herpesvirus 8 prevalence in human immunodeficiency virus-associated oral mucosal lesions.
|
J Infect Dis
|
1997
|
0.78
|
|
80
|
Alterations on chromosome 3 in endemic and nonendemic nasopharyngeal carcinoma.
|
Int J Cancer
|
2000
|
0.76
|
|
81
|
Human neonatal lymphocytes immortalized after microinjection of Epstein-Barr virus DNA.
|
J Virol
|
1987
|
0.75
|
|
82
|
Burkitt's and other non-Hodgkin's lymphomas in adults exposed to a visitor from Africa.
|
N Engl J Med
|
1985
|
0.75
|
|
83
|
Transformation of hairy cell leukemia to EBV genome-containing aggressive B cell lymphoma.
|
Leukemia
|
1987
|
0.75
|
|
84
|
Transforming activity of nasopharyngeal carcinoma DNA detectable in mouse JB6 cells.
|
Int J Cancer
|
1989
|
0.75
|
|
85
|
Successful immune reconstitution in severe combined immunodeficiency despite Epstein-Barr virus and cytomegalovirus infections.
|
Clin Immunol Immunopathol
|
1985
|
0.75
|
|
86
|
Detection of Epstein-Barr virus in human tissues by molecular genetic techniques.
|
Arch Pathol Lab Med
|
1993
|
0.75
|
|
87
|
Acute monoarthritis from infectious mononucleosis.
|
Am J Med
|
1999
|
0.75
|
|
88
|
Epstein-Barr virus-related lymphomagenesis in a child with Wiskott-Aldrich syndrome.
|
Hematol Oncol
|
1994
|
0.75
|